Cambridge Healthtech Institute Training Seminars offer real-life case studies, problems encountered, and solutions applied, along with extensive coverage of the academic theory and background. Each training seminar offers a mix of formal lecture and interactive discussions and activities to maximize the learning experience. These training seminars are led by experienced instructors who will focus on content applicable to your current research and provide important guidance for those new to their fields.

Training Seminars Will Be Offered In Person Only
To ensure a cohesive and focused learning environment, moving
between conference sessions and the training seminars is not allowed.

2026 Training Seminars:

TS: Introduction to Multispecific Antibodies: History, Engineering, and Applications
Instructor: G. Jonah Rainey, PhD, Associate Vice President, Eli Lilly and Company

TS: Everything You Ever Wanted to Know about Immunogenicity
Instructors: Sofie Pattyn, Founder & CTO, IQVIA Laboratories
                   Chloé Ackaert, PhD, Senior Scientist, Immunogenicity, IQVIA Laboratories
                   Timothy Hickling, PhD, Consultant, Quasor Ltd.

TS: AI-Driven Design of Biologics: A Hands-on Guide to Using State-of-the-Art ML Protein Models
Instructor: David P. Nannemann, PhD, Vice President, Rosetta Commons Foundation

TS: Introduction to Machine Learning for Biologics Design
Instructor: Christopher R. Corbeil, PhD, Research Officer, Human Health Therapeutics, National Research Council Canada

Conference Programs

• Display of Biologics
• Engineering Antibodies
• Machine Learning Part 2

• Antibody-Based Therapies
• Autoimmune Diseases
• Challenging Targets

• Safety & Efficacy
• Advancing Multispecifics
• Engineering Bispecifics

• T Cell Engagers
• Immunoengineering
• Next-Gen Immunotherapies

• Optimisation & Developability
• Analytical Characterisation
• Protein Stability & Formulation

• Leveraging Data Science
• Optimising Expression
• Discovery Workflows

• AI-Driven Design
• Machine Learning Part 1
• Machine Learning Part 2

• Antibody-Based Therapies
• Engineering Conjugates
• Peptide Drug Discovery

---

---

Related Event